330784-47-9

We have more than 10 years of experience in custom synthesis of compounds. If you are looking for a supplier or manufacturer of Avanafil (CAS No.: 330784-47-9) please contact us. We can provide customers with custom synthesis from grams to kilograms and the production of tons of compounds. Now, we also hope to meet your needs for Avanafil (CAS No.: 330784-47-9) and other compounds. We can provide high-quality compounds and good service fou you.

Send Inquiry

Product Description

Name	Avanafil
Synonyms	(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
Molecular Formula	C₂₃H₂₆ClN₇O₃
Molecular Weight	483.95100
CAS Number	330784-47-9
purity	≥98%
Storage conditions	Sealed in dry,Store in freezer, under -20°C

Application: Avanafil is a PDE5 inhibitor approved for erectile dysfunction by the FDA on April 27, 2012 and by EMA on June 21, 2013. Avanafil is known by the trademark names Stendra and Spedra and was developed by Vivus Inc. In July 2013 Vivus announced partnership with Menarini Group, which will commercialise and promote Spedra in over 40 European countries plus Australia and New Zealand. Avanafil acts by inhibiting a specific phosphodiesterase type 5 enzyme which is found in various body tissues, but primarily in the corpus cavernosum penis, as well as the retina. Other similar drugs are sildenafil, tadalafil and vardenafil. The advantage of avanafil is that it has very fast onset of action compared with other PDE5 inhibitors. It is absorbed quickly, reaching a maximum concentration in about 30–45 minutes. About two-thirds of the participants were able to engage in sexual activity within 15 minutes.

Hot Tags: